| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10911789 | Lung Cancer | 2005 | 8 Pages | 
Abstract
												In conclusion, the results of this study suggest that loss of p16 expression by promoter hypermethylation is inconsistently and occurs late in the carcinogenic process at the level of severe dysplasia. To what extent overexpression of the polycomb-group protein BMI-1 attributes to down regulating of p16 expression remains unclear.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												R.H.J. Breuer, P.J.F. Snijders, G.T. Sutedja, R.G.A.B. Sewalt, A.P. Otte, P.E. Postmus, C.J.L.M. Meijer, F.M. Raaphorst, E.F. Smit, 
											